Identification of unapproved orthopedic regenerative medicine: Usefulness of the Act on Safety of Regenerative Medicine.

Authors :: Ukon Y
Hosoya S
Morita K
Yokozeki Y
Kataoka T
Kitahara T
Mae H
Kanie Y
Furuya M
Fujimori T
Kaito T
Okada K
Myoui A
Okada S
Source :: Stem cell reports [Stem Cell Reports] 2024 May 14; Vol. 19 (5), pp. 597-603. Date of Electronic Publication: 2024 May 02.
Publication Year :: 2024
Abstract: In Japan, the Act on Safety of Regenerative Medicine regulates unapproved regenerative medicine. Other nations market regenerative medicine products, bypassing regulatory approval. To identify unapproved orthopedic regenerative medicine, we have used data based on the Act. Platelet-rich plasma was often used. The common target was the knee. Prices averaged $2,490.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)

Subjects :: Humans
Japan
Platelet-Rich Plasma metabolism
Regenerative Medicine
Orthopedics

Full Text Access

Tools